Molecular heterogeneity of sporadic adult Burkitt-type leukemia/lymphoma as revealed by PCR and cytogenetics: Correlation with morphology, immunology and clinical features

Leukemia

Volumn 19, Issue 8, 2005, Pages 1391-1398

  Burmeister, Thomas ^a   Schwartz, S ^a   Horst, H A ^b   Rieder, H ^c   Gokbuget N ^d   Hoelzer, D ^d   Thiel, E ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d GOETHE UNIVERSITY   (Germany)

Author keywords

FAB classification; Isotype switch; Mature B ALL; VDJ recombination

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN HEAVY CHAIN; METHOTREXATE;

ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BURKITT LYMPHOMA; CANCER SURVIVAL; CELL STRUCTURE; CHROMOSOME 11P; CHROMOSOME 11Q; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 2; CHROMOSOME TRANSLOCATION 22; CHROMOSOME TRANSLOCATION 8; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOGENETICS; DRUG MEGADOSE; EPSTEIN BARR VIRUS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE TRANSLOCATION; GENETIC ANALYSIS; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; HUMAN TISSUE; IMMUNOPHENOTYPING; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NONHUMAN; ONCOGENE MYC; PREDICTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RELIABILITY; VIRUS DETECTION;

EID: 23744451790     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403847     Document Type: Article

References (30)

1. Diebold J, Jaffe ES, Raphael M, Warnke RA. Burkitt lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds). Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press, 2001, pp 181-184.
2. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-1392.
3. Boxer LM, Dang CV. Translocations involving c-myc and c-myc function. Oncogene 2001; 20: 5595-5610.
4. Bornkamm GW, Polack A, Eick D. c-Myc Deregulation by Chromosomal Translocation in Burkitt's Lymphoma. New York: M Decker Inc., 1988.
5. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR et al. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 1976; 33: 451-458.
6. Navid F, Mosijczuk AD, Head DR, Borowitz MJ, Carroll AJ, Brandt JM et al. Acute lymphoblastic leukemia with the (8;14)(q24;q32) translocation and FAB L3 morphology associated with a B-precursor immunophenotype: the Pediatric Oncology Group experience. Leukemia 1999; 13: 135-141.
7. Komrokji R, Lancet J, Felgar R, Wang N, Bennett JM. Burkitt's leukemia with precursor B-cell immunophenotype and atypical morphology (atypical Burkitt's leukemia/lymphoma): case report and review of literature. Leuk Res 2003; 27: 561-566.
8. Schwartz S, Rieder H, Schläger B, Burmeister T, Fischer L, Thiel E. Expression of the human homologue of rat NG2 in adult acute lymphoblastic leukemia: close association with MLL rearrangement and a CD10(-)/CD24(-)/CD65s(+)/CD15(+) B-cell phenotype. Leukemia 2003; 17: 1589-1595.
9. Magrath IT, Pizzo PA, Whang-Peng J, Douglass EC, Alabaster O, Gerber P et al. Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. I. Physical, cytogenetic, and growth characteristics. J Natl Cancer Inst 1980; 64: 465-476.
10. Pulvertaft RJ. Cytology of Burkitt's tumour (African lymphoma). Lancet 1964; 1: 238-240.
11. Ben-Bassat H, Goldblum N, Mitrani S, Goldblum T, Yoffey JM, Cohen MM et al. Establishment in continuous culture of a new type of lymphocyte from a 'Burkitt like' malignant lymphoma (line D.G.-75). Int J Cancer 1977; 19: 27-33.
12. Klein G, Giovanella B, Westman A, Stehlin JS, Mumford D. An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectability and permanent conversion into EBV-positive sublines by in vitro infection. Intervirology 1975; 5: 319-334.
13. Gao SJ, Kingsley L, Li M, Zheng W, Parravicini C, Ziegler J et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 1996; 2: 925-928.
14. Akasaka T, Muramatsu M, Ohno H, Miura I, Tatsumi E, Fukuhara S et al. Application of long-distance polymerase chain reaction to detection of junctional sequences created by chromosomal translocation in mature B-cell neoplasms. Blood 1996; 88: 985-994.
15. Basso K, Frascella E, Zanesco L, Rosolen A. Improved long-distance polymerase chain reaction for the detection of t(8;14)(q24;q32) in Burkitt's lymphomas. Am J Pathol 1999; 155: 1479-1485.
16. Crescenzi M, Seto M, Herzig GP, Weiss PD, Griffith RC, Korsmeyer SJ. Thermostable DNA polymerase chain amplification of t(14;18) chromosome breakpoints and detection of minimal residual disease. Proc Natl Acad Sci USA 1988; 85: 4869-4873.
17. Cinque P, Brytting M, Vago L, Castagna A, Parravicini C, Zanchetta N et al. Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system. Lancet 1993; 342: 398-401.
18. Rieder H, Bonwetsch C, Janssen LA, Maurer J, Janssen JW, Schwartz S et al. High rate of chromosome abnormalities detected by fluorescence in situ hybridization using BCR and ABL probes in adult acute lymphoblastic leukemia. Leukemia 1998; 12: 1473-1481.
19. Stevens SJ, Vervoort MB, van den Brule AJ, Meenhorst PL, Meijer CJ, Middeldorp JM. Monitoring of Epstein-Barr virus DNA load in peripheral blood by quantitative competitive PCR. J Clin Microbiol 1999; 37: 2852-2857.
20. Hermouet S, Sutton CA, Rose TM, Greenblatt RJ, Corre I, Garand R et al. Qualitative and quantitative analysis of human herpesviruses in chronic and acute B cell lymphocytic leukemia and in multiple myeloma. Leukemia 2003; 17: 185-195.
21. Hoelzer D, Ludwig WD, Thiel E, Gassmann W, Löffler H, Fonatsch C et al. Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood 1996; 87: 495-508.
22. Nacheva E, Dyer MJ, Fischer P, Stranks G, Heward JM, Marcus RE et al. C-MYC translocations in de novo B-cell lineage acute leukemias with t(14;18) (cell lines Karpas 231 and 353). Blood 1993; 82: 231-240.
23. Dunphy CH, van Deventer HW, Carder KJ, Rao KW, Dent GA. Mature B-cell acute lymphoblastic leukemia with associated translocations (14;18)(q32;q21) and (8;9)(q24;p13). A Burkitt variant? Arch Pathol Lab Med 2003; 127: 610-613.
24. Mussolin L, Basso K, Pillon M, d'Amore ES, Lombardi A, Luzzatto L et al. Prospective analysis of minimal bone marrow infiltration in pediatric Burkitt's lymphomas by long-distance polymerase chain reaction for t(8;14)(q24;q32). Leukemia 2003; 17: 585-589.
25. Shiramizu B, Barriga F, Neequaye J, Jafri A, Dalla-Favera R, Neri A et al. Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: relevance to geography and Epstein-Barr virus association. Blood 1991; 77: 1516-1526.
26. Saglio G, Borrello MG, Guerrasio A, Sozzi G, Serra A, di Celle PF et al. Preferential clustering of chromosomal breakpoints in Burkitt's lymphomas and L3 type acute lymphoblastic leukemias with a t(8;14) translocation. Genes Chromosomes Cancer 1993; 8: 1-7.
27. Thorley-Lawson DA, Gross A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 2004; 350: 1328-1337.
28. Hecht JL, Aster JC. Molecular biology of Burkitt's lymphoma. J Clin Oncol 2000; 18: 3707-3721.
29. Schulz TF. Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8). J Gen Virol 1998; 79: 1573-1591.
30. Au WY, Horsman DE, Gascoyne RD, Viswanatha DS, Klasa RJ, Connors JM. The spectrum of lymphoma with 8q24 aberrations: a clinical, pathological and cytogenetic study of 87 consecutive cases. Leuk Lymphoma 2004; 45: 519-528.